Hamamatsu Pharma Research, Inc. is dedicated to preclinical efficacy evaluation of novel therapeutics in non-human primate disease models, including pain (chemotherapy-induced neuropathic pain & osteoarthritis) and cerebral ischemia/stroke.
Hamamatsu Pharma Research, Inc. is dedicated to preclinical efficacy evaluation of novel therapeutics in non-human primate disease models, including pain (chemotherapy-induced neuropathic pain & osteoarthritis) and cerebral ischemia/stroke.